aluates Reports

$ 0.0

Automative

Global Nephrology Drugs Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-38P9826

Global Nephrology Drugs Market Research Report 2022

BUY CHAPTERS

Global Nephrology Drugs Market Research Report 2025

Code: QYRE-Auto-38P9826

Report

March 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Pfizer Inc

Amgen Inc

FibroGen Inc

GlaxoSmithKline PLC

AbbVie

Akebia Therapeutics

Teva Pharmaceutical Industries

Johnson & Johnson

Roche

Nephrology Drugs Market Size

The global market for Nephrology Drugs was valued at US$ 735 million in the year 2024 and is projected to reach a revised size of US$ 1141 million by 2031, growing at a CAGR of 6.6% during the forecast period.

Nephrology Drugs Market

Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nephrology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nephrology Drugs.

The Nephrology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nephrology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nephrology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nephrology Drugs Market Report

Report Metric	Details
Report Name	Nephrology Drugs Market
Accounted market size in year	US$ 735 million
Forecasted market size in 2031	US$ 1141 million
CAGR	6.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	ACE Inhibitors Calcium Channel Blocker Beta Blockers Diuretics Others
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Pfizer, Amgen, FibroGen, GlaxoSmithkline, AbbVie, Akebia Therapeutics, Teva Pharmaceutical Industries, Johnson & Johnson, Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nephrology Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nephrology Drugs Market growing?

Ans: The Nephrology Drugs Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the Nephrology Drugs Market size in 2031?

Ans: The Nephrology Drugs Market size in 2031 will be US$ 1141 million.

Who are the main players in the Nephrology Drugs Market report?

Ans: The main players in the Nephrology Drugs Market are AstraZeneca, Pfizer, Amgen, FibroGen, GlaxoSmithkline, AbbVie, Akebia Therapeutics, Teva Pharmaceutical Industries, Johnson & Johnson, Roche

What are the Application segmentation covered in the Nephrology Drugs Market report?

Ans: The Applications covered in the Nephrology Drugs Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Nephrology Drugs Market report?

Ans: The Types covered in the Nephrology Drugs Market report are ACE Inhibitors, Calcium Channel Blocker, Beta Blockers, Diuretics, Others

Recommended Reports

Kidney Disease Drugs

Pharmaceutical Drugs

Diagnostics & Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nephrology Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 ACE Inhibitors

1.2.3 Calcium Channel Blocker

1.2.4 Beta Blockers

1.2.5 Diuretics

1.2.6 Others

1.3 Market by Application

1.3.1 Global Nephrology Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nephrology Drugs Market Perspective (2020-2031)

2.2 Global Nephrology Drugs Growth Trends by Region

2.2.1 Global Nephrology Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nephrology Drugs Historic Market Size by Region (2020-2025)

2.2.3 Nephrology Drugs Forecasted Market Size by Region (2026-2031)

2.3 Nephrology Drugs Market Dynamics

2.3.1 Nephrology Drugs Industry Trends

2.3.2 Nephrology Drugs Market Drivers

2.3.3 Nephrology Drugs Market Challenges

2.3.4 Nephrology Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nephrology Drugs Players by Revenue

3.1.1 Global Top Nephrology Drugs Players by Revenue (2020-2025)

3.1.2 Global Nephrology Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Nephrology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nephrology Drugs Revenue

3.4 Global Nephrology Drugs Market Concentration Ratio

3.4.1 Global Nephrology Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nephrology Drugs Revenue in 2024

3.5 Global Key Players of Nephrology Drugs Head office and Area Served

3.6 Global Key Players of Nephrology Drugs, Product and Application

3.7 Global Key Players of Nephrology Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nephrology Drugs Breakdown Data by Type

4.1 Global Nephrology Drugs Historic Market Size by Type (2020-2025)

4.2 Global Nephrology Drugs Forecasted Market Size by Type (2026-2031)

5 Nephrology Drugs Breakdown Data by Application

5.1 Global Nephrology Drugs Historic Market Size by Application (2020-2025)

5.2 Global Nephrology Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nephrology Drugs Market Size (2020-2031)

6.2 North America Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nephrology Drugs Market Size by Country (2020-2025)

6.4 North America Nephrology Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nephrology Drugs Market Size (2020-2031)

7.2 Europe Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nephrology Drugs Market Size by Country (2020-2025)

7.4 Europe Nephrology Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nephrology Drugs Market Size (2020-2031)

8.2 Asia-Pacific Nephrology Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nephrology Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Nephrology Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nephrology Drugs Market Size (2020-2031)

9.2 Latin America Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nephrology Drugs Market Size by Country (2020-2025)

9.4 Latin America Nephrology Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nephrology Drugs Market Size (2020-2031)

10.2 Middle East & Africa Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nephrology Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Nephrology Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Nephrology Drugs Introduction

11.1.4 AstraZeneca Revenue in Nephrology Drugs Business (2020-2025)

11.1.5 AstraZeneca Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Nephrology Drugs Introduction

11.2.4 Pfizer Revenue in Nephrology Drugs Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Amgen

11.3.1 Amgen Company Details

11.3.2 Amgen Business Overview

11.3.3 Amgen Nephrology Drugs Introduction

11.3.4 Amgen Revenue in Nephrology Drugs Business (2020-2025)

11.3.5 Amgen Recent Development

11.4 FibroGen

11.4.1 FibroGen Company Details

11.4.2 FibroGen Business Overview

11.4.3 FibroGen Nephrology Drugs Introduction

11.4.4 FibroGen Revenue in Nephrology Drugs Business (2020-2025)

11.4.5 FibroGen Recent Development

11.5 GlaxoSmithkline

11.5.1 GlaxoSmithkline Company Details

11.5.2 GlaxoSmithkline Business Overview

11.5.3 GlaxoSmithkline Nephrology Drugs Introduction

11.5.4 GlaxoSmithkline Revenue in Nephrology Drugs Business (2020-2025)

11.5.5 GlaxoSmithkline Recent Development

11.6 AbbVie

11.6.1 AbbVie Company Details

11.6.2 AbbVie Business Overview

11.6.3 AbbVie Nephrology Drugs Introduction

11.6.4 AbbVie Revenue in Nephrology Drugs Business (2020-2025)

11.6.5 AbbVie Recent Development

11.7 Akebia Therapeutics

11.7.1 Akebia Therapeutics Company Details

11.7.2 Akebia Therapeutics Business Overview

11.7.3 Akebia Therapeutics Nephrology Drugs Introduction

11.7.4 Akebia Therapeutics Revenue in Nephrology Drugs Business (2020-2025)

11.7.5 Akebia Therapeutics Recent Development

11.8 Teva Pharmaceutical Industries

11.8.1 Teva Pharmaceutical Industries Company Details

11.8.2 Teva Pharmaceutical Industries Business Overview

11.8.3 Teva Pharmaceutical Industries Nephrology Drugs Introduction

11.8.4 Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2020-2025)

11.8.5 Teva Pharmaceutical Industries Recent Development

11.9 Johnson & Johnson

11.9.1 Johnson & Johnson Company Details

11.9.2 Johnson & Johnson Business Overview

11.9.3 Johnson & Johnson Nephrology Drugs Introduction

11.9.4 Johnson & Johnson Revenue in Nephrology Drugs Business (2020-2025)

11.9.5 Johnson & Johnson Recent Development

11.10 Roche

11.10.1 Roche Company Details

11.10.2 Roche Business Overview

11.10.3 Roche Nephrology Drugs Introduction

11.10.4 Roche Revenue in Nephrology Drugs Business (2020-2025)

11.10.5 Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Pfizer Inc

Amgen Inc

FibroGen Inc

GlaxoSmithKline PLC

AbbVie

Akebia Therapeutics

Teva Pharmaceutical Industries

Johnson & Johnson

Roche

List of Tables

Table 1. Global Nephrology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of ACE Inhibitors

Table 3. Key Players of Calcium Channel Blocker

Table 4. Key Players of Beta Blockers

Table 5. Key Players of Diuretics

Table 6. Key Players of Others

Table 7. Global Nephrology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nephrology Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nephrology Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Nephrology Drugs Market Share by Region (2020-2025)

Table 11. Global Nephrology Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Nephrology Drugs Market Share by Region (2026-2031)

Table 13. Nephrology Drugs Market Trends

Table 14. Nephrology Drugs Market Drivers

Table 15. Nephrology Drugs Market Challenges

Table 16. Nephrology Drugs Market Restraints

Table 17. Global Nephrology Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Nephrology Drugs Market Share by Players (2020-2025)

Table 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2024)

Table 20. Ranking of Global Top Nephrology Drugs Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Nephrology Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Nephrology Drugs, Headquarters and Area Served

Table 23. Global Key Players of Nephrology Drugs, Product and Application

Table 24. Global Key Players of Nephrology Drugs, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Nephrology Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Nephrology Drugs Revenue Market Share by Type (2020-2025)

Table 28. Global Nephrology Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Nephrology Drugs Revenue Market Share by Type (2026-2031)

Table 30. Global Nephrology Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Nephrology Drugs Revenue Market Share by Application (2020-2025)

Table 32. Global Nephrology Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Nephrology Drugs Revenue Market Share by Application (2026-2031)

Table 34. North America Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Nephrology Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Nephrology Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Nephrology Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 49. AstraZeneca Company Details

Table 50. AstraZeneca Business Overview

Table 51. AstraZeneca Nephrology Drugs Product

Table 52. AstraZeneca Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 53. AstraZeneca Recent Development

Table 54. Pfizer Company Details

Table 55. Pfizer Business Overview

Table 56. Pfizer Nephrology Drugs Product

Table 57. Pfizer Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 58. Pfizer Recent Development

Table 59. Amgen Company Details

Table 60. Amgen Business Overview

Table 61. Amgen Nephrology Drugs Product

Table 62. Amgen Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 63. Amgen Recent Development

Table 64. FibroGen Company Details

Table 65. FibroGen Business Overview

Table 66. FibroGen Nephrology Drugs Product

Table 67. FibroGen Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 68. FibroGen Recent Development

Table 69. GlaxoSmithkline Company Details

Table 70. GlaxoSmithkline Business Overview

Table 71. GlaxoSmithkline Nephrology Drugs Product

Table 72. GlaxoSmithkline Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 73. GlaxoSmithkline Recent Development

Table 74. AbbVie Company Details

Table 75. AbbVie Business Overview

Table 76. AbbVie Nephrology Drugs Product

Table 77. AbbVie Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 78. AbbVie Recent Development

Table 79. Akebia Therapeutics Company Details

Table 80. Akebia Therapeutics Business Overview

Table 81. Akebia Therapeutics Nephrology Drugs Product

Table 82. Akebia Therapeutics Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 83. Akebia Therapeutics Recent Development

Table 84. Teva Pharmaceutical Industries Company Details

Table 85. Teva Pharmaceutical Industries Business Overview

Table 86. Teva Pharmaceutical Industries Nephrology Drugs Product

Table 87. Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 88. Teva Pharmaceutical Industries Recent Development

Table 89. Johnson & Johnson Company Details

Table 90. Johnson & Johnson Business Overview

Table 91. Johnson & Johnson Nephrology Drugs Product

Table 92. Johnson & Johnson Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 93. Johnson & Johnson Recent Development

Table 94. Roche Company Details

Table 95. Roche Business Overview

Table 96. Roche Nephrology Drugs Product

Table 97. Roche Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)

Table 98. Roche Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Nephrology Drugs Picture

Figure 2. Global Nephrology Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nephrology Drugs Market Share by Type: 2024 VS 2031

Figure 4. ACE Inhibitors Features

Figure 5. Calcium Channel Blocker Features

Figure 6. Beta Blockers Features

Figure 7. Diuretics Features

Figure 8. Others Features

Figure 9. Global Nephrology Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Nephrology Drugs Market Share by Application: 2024 VS 2031

Figure 11. Hospital Pharmacy Case Studies

Figure 12. Retail Pharmacy Case Studies

Figure 13. Online Pharmacy Case Studies

Figure 14. Nephrology Drugs Report Years Considered

Figure 15. Global Nephrology Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nephrology Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nephrology Drugs Market Share by Region: 2024 VS 2031

Figure 18. Global Nephrology Drugs Market Share by Players in 2024

Figure 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nephrology Drugs Revenue in 2024

Figure 21. North America Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nephrology Drugs Market Share by Country (2020-2031)

Figure 23. United States Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nephrology Drugs Market Share by Country (2020-2031)

Figure 27. Germany Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nephrology Drugs Market Share by Region (2020-2031)

Figure 35. China Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nephrology Drugs Market Share by Country (2020-2031)

Figure 43. Mexico Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nephrology Drugs Market Share by Country (2020-2031)

Figure 47. Turkey Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. AstraZeneca Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 52. Amgen Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 53. FibroGen Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 54. GlaxoSmithkline Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 55. AbbVie Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 56. Akebia Therapeutics Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 58. Johnson & Johnson Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 59. Roche Revenue Growth Rate in Nephrology Drugs Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Renal Diseases Drug Market Insights Forecast to 2030

End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024

Global Kidney Medicine Market Insights Forecast to 2030

Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dialysis Drug Market Research Report 2024

Ophthalmology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemodialysis Drug Market Research Report 2024

Drugs for Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug induced Nephrotoxicity Treatment Market Research Report 2025

Global Renal Therapeutic Market Research Report 2025

Global Chronic Kidney Disease Medication Market Research Report 2024

Global Renal Disease Treatment Market Research Report 2024

Ophthalmology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease Drugs Market Research Report 2025

Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions